TSRNOSS, page 1.

seen from China

seen from United Kingdom

seen from United Kingdom
seen from Kuwait
seen from China
seen from Maldives
seen from United States
seen from Belarus
seen from United States
seen from United States
seen from United Kingdom

seen from China
seen from United States
seen from France

seen from Denmark
seen from Chile
seen from United States

seen from United States

seen from Malaysia

seen from China
TSRNOSS, page 1.
The Research Manuscripts of S. Sunkavally, p 670.
Use of Lithium/ Iodine Combination for Grave’s Disease
Use of Lithium/ Iodine Combination for Grave’s Disease
Use of Lithium/ Iodine Combination for Grave’s Disease by Jeffrey Dach MD In this article, we will present the case for combined use of Lithium carbonate and Iodine for treatment of Graves Autoimmune hyperthyroidism. Header Image Thyroid Gland Microscopic View of Graves Disease Courtesy of WIkimedia Commons. Lithium for Manic Depression Lithium Carbonate has been used as a psychiatric drug to…
View On WordPress
Hyperthyroidism | Human Biospecimens | Order Online
Hyperthyroidism is a lifelong endocrine disease called caused by an overactive thyroid gland that secretes too much T3, T4, or both into the systemic circulation. It is primarily brought on by toxic multinodular goitre, toxic adenomas, and autoimmune Graves disease. Thyrotoxicosis is another name of hyperthyroidism. However, the precise causes of hyperthyroidism is still unclear. In addition, women are more likely to have hyperthyroidism than males in the same age group. Click CLINICAL DIAGNOSIS, ICD-10-CM CODES, and LABORATORY PARAMETERS to view advanced search options.
What are the symptoms and causes of Hyperthyroidism
In the human body, the tiny butterfly-like gland located at the front part of the neck is called the thyroid gland. It plays a vital role in regulating body metabolism by producing the thyroid hormones Triiodothyronine (T3) and thyroxine (T4). Any imbalance in the number of hormones synthesized and secreted to the bloodstream is known as a thyroid disorder.
Hyperthyroidism is when an overactive thyroid gland secretes too much T3 and T4 into the bloodstream speeding up the metabolic process. The primary causes of Hyperthyroidism include autoimmune Grave's disease, multinodular goiter and toxic adenomas. Hyperthyroidism is also known as thyrotoxicosis and affects more women than men in the same age range.
Signs and Symptoms of Hyperthyroidism:
Often clinical signs and symptoms of Hyperthyroidism are misdiagnosed as other conditions. Moreover, the patient remains asymptomatic in the early phase of the illness and remains undiagnosed for a long time. Common signs and symptoms of Hyperthyroidism are sudden unintended excessive weight loss, elevated anxiety, irritability, trouble sleeping, irregular menstrual cycles in women, goiter, heat sensitivity, hazy vision, and proximal muscle weakness. In a nutshell, Hyperthyroidism causes significant troubles affecting the patient's quality of life.
Who is at high risk of thyroid diseases?
Hyperthyroidism can affect anyone of any age. Below are the populations that are at high risk for developing this disease.
People with a family history of thyroid diseases
Patients taking certain medications like amiodarone
Females
Patients suffering from other autoimmune conditions like type-1 diabetes mellitus, systemic lupus erythematosus (SLE), and Sjögren's syndrome
Persons who underwent past treatment for thyroid disease or cancer
People more than 60 years old, especially women
How is Hyperthyroidism treated?
There is no complete cure for Hyperthyroidism. It means the patients have to take lifelong treatment to control the disease symptoms and avoid complications of the disease. Overproduction of thyroid hormones by the thyroid gland can be effectively treated by hyperthyroidism medications such as Methimazole, radioactive iodine, and propylthiouracil to restore normal thyroid function. Besides, surgical removal of the overactive thyroid gland may be necessary for some patients to prevent disease progression and disease-related complications.
Central BioHub opens up the largest collection of hyperthyroidism samples for research.
Central BioHub provides online access to the largest biospecimen collection by putting an end to the traditional method of acquiring research biospecimens. It brings you superior human biomaterials ideal for in-vitro research in various biomedical sectors such as pharmaceuticals, biotech, medical and diagnostic industries.
Leveraging major breakthroughs in Hyperthyroidism research, Central BioHub is specialized in bringing high-quality, richly annotated human biospecimens collected from patients of different ages, gender and ethnicities across the globe. Its inventory contains human serum and plasma samples critically measured for routine biochemical investigations like a thyroid-stimulating hormone (TSH) or thyrotropin, triiodothyronine (T3), thyroxine (T4), and thyroglobulin (Tg). Moreover, samples are subjected to antibody testing like TSH receptor antibodies (TRAb), thyroid peroxidase (TPO / MAK), anti-thyroid peroxidase antibodies (anti-TPO), and anti-thyroglobulin (aTg /TAK). Being an online biospecimen marketplace, every sample is readily available in stock where researchers can purchase directly from our online store: https://centralbiohub.de/biospecimens/endocrine-disorders/hyperthyroidism
Novel Connections between the Thyroid and the Heart uncovered in a Large Meta-Analysis
https://link.growkudos.com/1nw41ea9ds0
Screening the Thyroid before Initiating Treatment for Acromegaly? | Chapter 06 | Current Trends in Medicine and Medical Research Vol. 4
Aim: To present a case of acromegaly with coexisting thyrotoxicosis and to emphasize the relevance of screening the screening the thyroid before initiating treatment for thyrotoxicosis.
Presentation of the Case: A 55-year-old lady presented with palpitations, and weight loss of two months’ duration. She also noted her fingers and toes had swollen up, inability to incise properly since two years. Upon examination, she had morphological features clinically diagnostic of acromegaly. Her thyroid was enlargedwas on investigation found to have biochemical evidence of thyrotoxicosis. Fine needle aspiration cytology of the thyroid yielded colloid goiter. Insulin like growth factor-1 was elevated. Serum growth hormone after an oral glucose tolerance test was elevated. Magnetic resonant imaging (MRI) of the brain revealed a hypo enhancing focal lesion of size 11X10X12 mm at the pituitary region with delayed contrast enhancement suggestive of pituitary adenoma. Patient was started on anti-thyroid medications and referred to higher centre, and is awaiting surgery for pituitary adenoma.
Discussion: Among patients with acromegaly the incidence of thyroid diseases is around 78% and it has the most common presentation being nodular thyroid disease as the initial presentation. It is uncommon to see patients presenting with symptoms of thyrotoxicosis initially, who had florid morphological features of acromegaly. The prevalence of toxic nodular goiter to the tune of 14.3% in acromegaly. Goiters seen in acromegaly were euthyroid or autonomous, are due to the elevated growth hormone levels independent of TSH action. In about 13 to 17%, thyroidectomies were performed before acromegaly was diagnosed. When patients with acromegaly presents with a weight loss should arouse the possibilities of thyroid cancer or hyperthyroidism.
Conclusion: Screening the thyroid is important, as inadvertent thyroidectomies were performed before acromegaly was diagnosed. When acromegaly co-exists with thyroid dysfunction, the burden of cardiovascular abnormality should be addressed especially, to reduce the morbidity and mortality rate.
Author(s) Details
Dr. C. Rajasekharan
Department of Medicine, Medical College Hospital, Thiruvananthapuram, Kerala, 695011, India.
Read full article: http://bp.bookpi.org/index.php/bpi/catalog/view/43/185/333-1
View Volume: https://doi.org/10.9734/bpi/ctmmr/v4